SMS Co., Ltd.
SMS Co., Ltd. 2175.T Peers
See (2175.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2175.T | ¥1,501.50 | +6.26% | 124.9B | 20.73 | ¥70.93 | +1.94% |
| 2413.T | ¥1,893.00 | +3.22% | 1.3T | 31.20 | ¥59.61 | +1.13% |
| 4483.T | ¥3,916.00 | +3.98% | 250.4B | 43.37 | ¥88.31 | +0.42% |
| 4480.T | ¥3,110.00 | -0.48% | 99.9B | 45.03 | ¥69.06 | N/A |
| 3733.T | ¥13,500.00 | +1.43% | 70.7B | 15.03 | ¥898.43 | +0.96% |
| 9438.T | ¥937.00 | +2.52% | 51.1B | 19.88 | ¥46.43 | +1.84% |
| 4820.T | ¥724.00 | +0.84% | 49.8B | 16.86 | ¥42.77 | +5.96% |
| 6078.T | ¥1,717.00 | +1.72% | 45.2B | 57.23 | ¥29.55 | +1.54% |
| 5592.T | ¥3,175.00 | -0.78% | 35.5B | 17.54 | ¥180.48 | +0.85% |
| 2150.T | ¥736.00 | +2.94% | 30.8B | 24.98 | ¥28.74 | +1.67% |
Stock Comparison
2175.T vs 2413.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 2413.T has a market cap of 1.3T. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 2413.T trades at ¥1,893.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 2413.T's P/E ratio is 31.20. In terms of profitability, 2175.T's ROE is +0.13%, compared to 2413.T's ROE of +0.11%. Regarding short-term risk, 2175.T is more volatile compared to 2413.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4483.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4483.T has a market cap of 250.4B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4483.T trades at ¥3,916.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4483.T's P/E ratio is 43.37. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4483.T's ROE of +0.10%. Regarding short-term risk, 2175.T is less volatile compared to 4483.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4480.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4480.T has a market cap of 99.9B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4480.T trades at ¥3,110.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4480.T's P/E ratio is 45.03. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4480.T's ROE of +0.12%. Regarding short-term risk, 2175.T is more volatile compared to 4480.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3733.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3733.T has a market cap of 70.7B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3733.T trades at ¥13,500.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3733.T's P/E ratio is 15.03. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3733.T's ROE of +0.14%. Regarding short-term risk, 2175.T is more volatile compared to 3733.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 9438.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 9438.T has a market cap of 51.1B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 9438.T trades at ¥937.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 9438.T's P/E ratio is 19.88. In terms of profitability, 2175.T's ROE is +0.13%, compared to 9438.T's ROE of +0.16%. Regarding short-term risk, 2175.T is more volatile compared to 9438.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4820.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4820.T has a market cap of 49.8B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4820.T trades at ¥724.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4820.T's P/E ratio is 16.86. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4820.T's ROE of +0.10%. Regarding short-term risk, 2175.T is more volatile compared to 4820.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 6078.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 6078.T has a market cap of 45.2B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 6078.T trades at ¥1,717.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 6078.T's P/E ratio is 57.23. In terms of profitability, 2175.T's ROE is +0.13%, compared to 6078.T's ROE of +0.12%. Regarding short-term risk, 2175.T is more volatile compared to 6078.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 5592.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 5592.T has a market cap of 35.5B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 5592.T trades at ¥3,175.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 5592.T's P/E ratio is 17.54. In terms of profitability, 2175.T's ROE is +0.13%, compared to 5592.T's ROE of +0.27%. Regarding short-term risk, 2175.T is more volatile compared to 5592.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 2150.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 2150.T has a market cap of 30.8B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 2150.T trades at ¥736.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 2150.T's P/E ratio is 24.98. In terms of profitability, 2175.T's ROE is +0.13%, compared to 2150.T's ROE of +0.11%. Regarding short-term risk, 2175.T is more volatile compared to 2150.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3939.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3939.T has a market cap of 20.7B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3939.T trades at ¥439.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3939.T's P/E ratio is 21.15. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3939.T's ROE of +0.26%. Regarding short-term risk, 2175.T is more volatile compared to 3939.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3649.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3649.T has a market cap of 19B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3649.T trades at ¥743.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3649.T's P/E ratio is 16.42. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3649.T's ROE of +0.20%. Regarding short-term risk, 2175.T is more volatile compared to 3649.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3902.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3902.T has a market cap of 18.4B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3902.T trades at ¥509.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3902.T's P/E ratio is -23.50. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3902.T's ROE of -0.22%. Regarding short-term risk, 2175.T is less volatile compared to 3902.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 6095.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 6095.T has a market cap of 16.6B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 6095.T trades at ¥764.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 6095.T's P/E ratio is 9.71. In terms of profitability, 2175.T's ROE is +0.13%, compared to 6095.T's ROE of +0.18%. Regarding short-term risk, 2175.T is more volatile compared to 6095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 5585.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 5585.T has a market cap of 15.8B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 5585.T trades at ¥2,184.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 5585.T's P/E ratio is 58.47. In terms of profitability, 2175.T's ROE is +0.13%, compared to 5585.T's ROE of +0.11%. Regarding short-term risk, 2175.T is more volatile compared to 5585.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4263.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4263.T has a market cap of 14.6B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4263.T trades at ¥794.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4263.T's P/E ratio is -25.04. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4263.T's ROE of -0.06%. Regarding short-term risk, 2175.T is less volatile compared to 4263.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 9341.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 9341.T has a market cap of 12.3B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 9341.T trades at ¥706.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 9341.T's P/E ratio is 8.99. In terms of profitability, 2175.T's ROE is +0.13%, compared to 9341.T's ROE of +0.20%. Regarding short-term risk, 2175.T is more volatile compared to 9341.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4320.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4320.T has a market cap of 11.7B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4320.T trades at ¥699.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4320.T's P/E ratio is 23.70. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4320.T's ROE of +0.07%. Regarding short-term risk, 2175.T is more volatile compared to 4320.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 2934.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 2934.T has a market cap of 8.2B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 2934.T trades at ¥1,554.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 2934.T's P/E ratio is 91.21. In terms of profitability, 2175.T's ROE is +0.13%, compared to 2934.T's ROE of -1.32%. Regarding short-term risk, 2175.T is more volatile compared to 2934.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3628.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3628.T has a market cap of 7.6B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3628.T trades at ¥595.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3628.T's P/E ratio is -2.31. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3628.T's ROE of -1.24%. Regarding short-term risk, 2175.T is more volatile compared to 3628.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 3671.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 3671.T has a market cap of 7.5B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 3671.T trades at ¥312.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 3671.T's P/E ratio is 15.50. In terms of profitability, 2175.T's ROE is +0.13%, compared to 3671.T's ROE of +0.19%. Regarding short-term risk, 2175.T is more volatile compared to 3671.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 9218.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 9218.T has a market cap of 7B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 9218.T trades at ¥684.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 9218.T's P/E ratio is -227.89. In terms of profitability, 2175.T's ROE is +0.13%, compared to 9218.T's ROE of +0.26%. Regarding short-term risk, 2175.T is more volatile compared to 9218.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4172.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4172.T has a market cap of 5B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4172.T trades at ¥2,270.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4172.T's P/E ratio is 12.11. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4172.T's ROE of +0.10%. Regarding short-term risk, 2175.T is more volatile compared to 4172.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 6034.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 6034.T has a market cap of 4B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 6034.T trades at ¥706.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 6034.T's P/E ratio is -12.50. In terms of profitability, 2175.T's ROE is +0.13%, compared to 6034.T's ROE of -0.08%. Regarding short-term risk, 2175.T is more volatile compared to 6034.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 6545.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 6545.T has a market cap of 3.8B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 6545.T trades at ¥690.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 6545.T's P/E ratio is 15.01. In terms of profitability, 2175.T's ROE is +0.13%, compared to 6545.T's ROE of +0.17%. Regarding short-term risk, 2175.T is more volatile compared to 6545.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.
2175.T vs 4438.T Comparison
2175.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2175.T stands at 124.9B. In comparison, 4438.T has a market cap of 3B. Regarding current trading prices, 2175.T is priced at ¥1,501.50, while 4438.T trades at ¥359.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2175.T currently has a P/E ratio of 20.73, whereas 4438.T's P/E ratio is -3.63. In terms of profitability, 2175.T's ROE is +0.13%, compared to 4438.T's ROE of -0.88%. Regarding short-term risk, 2175.T is more volatile compared to 4438.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2175.T.